Shaw J - Search Results

1

Identification of the pharmacophore of the CC chemokine-binding proteins Evasin-1 and -4 using phage display.

Bonvin P, Dunn SM, Rousseau F, Dyer DP, Shaw J, Power CA, Handel TM, Proudfoot AEI. Bonvin P, et al. Among authors: shaw j. J Biol Chem. 2014 Nov 14;289(46):31846-31855. doi: 10.1074/jbc.M114.599233. Epub 2014 Sep 29. J Biol Chem. 2014. PMID: 25266725 Free PMC article.

2

Ticks produce highly selective chemokine binding proteins with antiinflammatory activity.

Déruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, Russo RC, Ferreira BR, Graham GJ, Shaw JP, Wells TN, Teixeira MM, Power CA, Proudfoot AE. Déruaz M, et al. Among authors: shaw jp. J Exp Med. 2008 Sep 1;205(9):2019-31. doi: 10.1084/jem.20072689. Epub 2008 Aug 4. J Exp Med. 2008. PMID: 18678732 Free PMC article.

3

Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3.

Dias JM, Losberger C, Déruaz M, Power CA, Proudfoot AE, Shaw JP. Dias JM, et al. PLoS One. 2009 Dec 30;4(12):e8514. doi: 10.1371/journal.pone.0008514. PLoS One. 2009. PMID: 20041127 Free PMC article.

4

A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins.

Lee AW, Deruaz M, Lynch C, Davies G, Singh K, Alenazi Y, Eaton JRO, Kawamura A, Shaw J, Proudfoot AEI, Dias JM, Bhattacharya S. Lee AW, et al. Among authors: shaw j. J Biol Chem. 2019 Jul 19;294(29):11199-11212. doi: 10.1074/jbc.RA119.008817. Epub 2019 Jun 5. J Biol Chem. 2019. PMID: 31167786 Free PMC article.

5

The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors.

Shaw JP, Johnson Z, Borlat F, Zwahlen C, Kungl A, Roulin K, Harrenga A, Wells TN, Proudfoot AE. Shaw JP, et al. Structure. 2004 Nov;12(11):2081-93. doi: 10.1016/j.str.2004.08.014. Structure. 2004. PMID: 15530372 Free article.

6

Chemokine blockers--therapeutics in the making?

Wells TN, Power CA, Shaw JP, Proudfoot AE. Wells TN, et al. Trends Pharmacol Sci. 2006 Jan;27(1):41-7. doi: 10.1016/j.tips.2005.11.001. Epub 2005 Nov 28. Trends Pharmacol Sci. 2006. PMID: 16310864 Review.

7

Protein therapeutics--lessons learned and a view of the future.

Johnson-Léger C, Power CA, Shomade G, Shaw JP, Proudfoot AE. Johnson-Léger C, et al. Expert Opin Biol Ther. 2006 Jan;6(1):1-7. doi: 10.1517/14712598.6.1.1. Expert Opin Biol Ther. 2006. PMID: 16370909 Review.

8

The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity.

Proudfoot AE, Fritchley S, Borlat F, Shaw JP, Vilbois F, Zwahlen C, Trkola A, Marchant D, Clapham PR, Wells TN. Proudfoot AE, et al. Among authors: shaw jp. J Biol Chem. 2001 Apr 6;276(14):10620-6. doi: 10.1074/jbc.M010867200. Epub 2000 Dec 14. J Biol Chem. 2001. PMID: 11116158 Free article.

9

Glycosaminoglycan analogs as a novel anti-inflammatory strategy.

Severin IC, Soares A, Hantson J, Teixeira M, Sachs D, Valognes D, Scheer A, Schwarz MK, Wells TN, Proudfoot AE, Shaw J. Severin IC, et al. Among authors: shaw j. Front Immunol. 2012 Oct 16;3:293. doi: 10.3389/fimmu.2012.00293. eCollection 2012. Front Immunol. 2012. PMID: 23087686 Free PMC article.

10

Crystallization and preliminary X-ray diffraction studies of human RANTES.

Shaw JP, Kryger G, Cleasby A, Wonacott A, Power CA, Proudfoot AE, Wells TN. Shaw JP, et al. J Mol Biol. 1994 Sep 30;242(4):589-90. doi: 10.1006/jmbi.1994.1605. J Mol Biol. 1994. PMID: 7523680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,937 results

Search Page